Universal COVID-19 Biobank: A subset of the Penn | Clinical Research Studies Listing

Universal COVID-19 Biobank: A subset of the Penn Medicine BioBank

Recruiting

18 years - 100 years

All

Phase N/A

1 Location

Brief description of study

The Universal COVID-19 Biobank – a component of the Penn Medicine Biobank – is collecting and storing biological specimens as well as information about people who may or may not have been exposed to the SARS-CoV-2 virus as well as those who have developed COVID-19 disease. This information will be used to help learn more about the risk of developing COVID-19 after exposure, to better understand why different people have different reactions to the virus, why some people get very sick from the virus while others don’t, and to better understand the how other diseases and conditions influence the severity of COVID-19.

Detailed description of study

The overall purpose of the biobank is to collect and store biological specimens, such as blood, urine, respiratory specimens, other bodily fluids, and tissue where available, as well as health information. Storing these samples and this information allows researchers to use them for research studies, including but not limited to COVID-19.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: covid19,healthy volunteers
Age: 18 years - 100 years
Gender: All

COVID-19, Coronavirus

Updated on 19 Feb 2024. Study ID: 813913

Pre-Screener

Compruebe si es elegible Ingrese los datos de contacto Selecciona un centro de estudios Select best time to contact

Are you a Penn Medicine Patient?

None

yes no

Preview complete

The prescreener preview is complete. You may now close the preview.